Avinza

   
Google
 
Web NewDrugInformation.com

Avinza


Drug - Avinza
The trade name of the product as shown on the labeling.

Dosage - CAPSULE, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Morphine Sulfate
Multiple ingredients are in alphabetical order.

Strength - 60MG
The potency of the active ingredient(s), Morphine Sulfate. May repeat for multiple part products.

Applicant - LIGAND
The firm name holding legal responsibility for Avinza. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021260
The FDA assigned number to Avinza. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Avinza. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - BX
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 20, 2002
The date Avinza was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Avinza. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Avinza is in. Format is RX, OTC, DISCN.

Applicant Full Name - Ligand Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Avinza.

Avinza